Doxazosin: A newly developed, selective α1-inhibitor in the management of patients with pheochromocytoma
- 31 December 1988
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 116 (6) , 1785-1789
- https://doi.org/10.1016/0002-8703(88)90230-x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Doxazosin in patients with hypertensionEuropean Journal of Clinical Pharmacology, 1988
- An open one-year comparison of doxazosin and prazosin for mild to moderate essential hypertensionPublished by Elsevier ,1987
- The alpha 1‐adrenoceptor antagonist profile of doxazosin: preclinical pharmacology.British Journal of Clinical Pharmacology, 1986
- Postjunctional Selectivity of α-Blockade with Prazosin, Trimazosin, and UK-33,274 in ManJournal of Cardiovascular Pharmacology, 1982
- Effects of Prazosin on Plasma Noradrenaline and Plasma Renin Concentrations in Hypertensive SubjectsJournal of Cardiovascular Pharmacology, 1980
- Preoperative and operative management of patients with phaeochromocytoma.BMJ, 1967
- Use of propranolol in conjunction with alpha receptor blocking drugs in pheochromocytomaThe American Journal of Cardiology, 1966